[Lapatinib is useful for metastatic breast cancer patients who cannot be treated with trastuzumab-report of a case].

Medicine and Dentistry

• Patient 100%
• Therapeutic Procedure 100%
• Metastatic Breast Cancer 100%
• Trastuzumab 100%
• Lapatinib 100%
• Breast 50%
• Liver Metastasis 50%
• Lesion 25%
• Echography 25%
• Diagnosis 25%
• Woman 25%
• Breast Carcinoma 25%
• Needle Biopsy 25%
• Mastectomy 25%
• Estrogen Receptor 25%
• Progesterone Receptor 25%
• Metastatic Carcinoma 25%
• Mammography 25%
• Retroperitoneal Lymph Node Dissection 25%
• Muscle 25%
• Protein Expression 25%
• Infusion 25%
• Distant Metastasis 25%
• Gamma Urogastrone 25%
• Capecitabine 25%
• Epidermal Growth Factor Receptor 2 25%
• Receptor Expression 25%

Nursing and Health Professions

• Trastuzumab 100%
• Metastatic Breast Cancer 100%
• Lapatinib 100%
• Needle Biopsy 25%
• Progesterone Receptor 25%
• Capecitabine 25%
• Estrogen Receptor 25%
• Distant Metastasis 25%
• Mammography 25%
• Breast Carcinoma 25%
• Lymph Node Dissection 25%
• Mastectomy 25%
• Epidermal Growth Factor Receptor 2 25%
• Hand Foot Syndrome 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Lapatinib 100%
• Hand Foot Syndrome 25%
• Epidermal Growth Factor Receptor 2 25%